Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha
- PMID: 16423039
- PMCID: PMC1782206
- DOI: 10.1111/j.1365-2567.2005.02261.x
Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha
Abstract
Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-gamma (IFN-gamma) and to exert lytic activity. Since NK cells lack the ISS receptor TLR9, the exact pathway by which NK cells are activated by ISS is unclear. We determined that ISS-induced IFN-gamma from NK cells is primarily dependent upon IFN-alpha release from plasmacytoid dendritic cells (PDCs), which directly activates the NK cell. However, further analysis indicated that other PDC-released soluble factor(s) may contribute to IFN-gamma induction. Indeed, tumour necrosis factor-alpha (TNF-alpha) was identified as a significant contributor to ISS-mediated activation of NK cells and was observed to act in an additive fashion with IFN-alpha in the induction of IFN-gamma from NK cells and to up-regulate CD69 expression on NK cells. This activity of TNF-alpha, however, was dependent upon the presence of PDC-derived factors such as type I interferon. These results illustrate an important function for type I interferon in innate immunity, which is not only to activate effectors like NK cells directly, but also to prime them for enhanced activation by other factors such as TNF-alpha.
Figures






Similar articles
-
Polymyxin B enhances ISS-mediated immune responses across multiple species.Cell Immunol. 2004 Jun;229(2):93-105. doi: 10.1016/j.cellimm.2004.04.009. Cell Immunol. 2004. PMID: 15474524
-
HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.Immunobiology. 2009;214(5):331-41. doi: 10.1016/j.imbio.2008.10.009. Epub 2009 Jan 18. Immunobiology. 2009. PMID: 19152985
-
Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.J Immunol. 1999 Oct 1;163(7):3642-52. J Immunol. 1999. PMID: 10490958
-
Killers and beyond: NK-cell-mediated control of immune responses.Eur J Immunol. 2008 Nov;38(11):2938-42. doi: 10.1002/eji.200838882. Eur J Immunol. 2008. PMID: 18979519 Review.
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
Cited by
-
Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology.Front Immunol. 2022 Sep 23;13:936235. doi: 10.3389/fimmu.2022.936235. eCollection 2022. Front Immunol. 2022. PMID: 36211447 Free PMC article. Review.
-
Nanoemulsions: A Review on the Conceptualization of Treatment for Psoriasis Using a 'Green' Surfactant with Low-Energy Emulsification Method.Pharmaceutics. 2021 Jul 6;13(7):1024. doi: 10.3390/pharmaceutics13071024. Pharmaceutics. 2021. PMID: 34371716 Free PMC article. Review.
-
Antiproliferative Properties of Type I and Type II Interferon.Pharmaceuticals (Basel). 2010 Mar 30;3(4):994-1015. doi: 10.3390/ph3040994. Pharmaceuticals (Basel). 2010. PMID: 20664817 Free PMC article.
-
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.Vaccine. 2010 Apr 19;28(18):3238-46. doi: 10.1016/j.vaccine.2010.02.010. Epub 2010 Feb 23. Vaccine. 2010. PMID: 20184975 Free PMC article.
-
Human plasmacytoid dendritic cells: from molecules to intercellular communication network.Front Immunol. 2013 Nov 12;4:372. doi: 10.3389/fimmu.2013.00372. eCollection 2013. Front Immunol. 2013. PMID: 24282405 Free PMC article. Review.
References
-
- Walker PS, Scharton-Kersten T, Krieg AM, Love-Homan L, Rowton ED, Udey MC, Vogel JC. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci USA. 1999;96:6970–5. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources